Biotech & Health Tech
The DEA banned a drug some opioid users called a miracle
Researchers say the Schedule I ban could kill studies of a promising opioid treatment.
Researchers say the Schedule I ban could kill studies of a promising opioid treatment.
This is a summary of the story. Read the full article at Ars Technica ↗